Cathie Wood's ARK Innovation Stocks Performance Guide: 10x Genomics (TXG)
TXG has no dividends
Table and Chart of TXG Performance
See what a $1,000 investment in TXG is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TXG Returns | |
|---|---|
| Start Date | Oct-31-2019 |
| Start Price | $58.00 |
| End Date | Nov-28-2023 |
| End Price | $42.16 |
| # Prices | 50 |
| Min Date | Oct-31-2022 |
| Min Price | $27.18 |
| Max Date | Apr-30-2021 |
| Max Price | $197.80 |
| Total Return | -27.31% |
| Annualized Return | -7.37% |
| Current Value of $1,000 Purchase | $727 |
| Number Returns | 1,225 |
| Average Return | -11.04% |
| Number Profitable Returns | 425 |
| Percent Profitable Returns | 34.69% |
| Number Unprofitable Returns | 800 |
| Percent Unprofitable Returns | 65.31% |
| Profitable to Unprofitable Returns Ratio | 0.53 |
| TXG Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,048,706,000 | Price to Sales | 8.13 |
| Earnings per Share | $-1.9200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 5.16 |
| PRICE DATA | |
| 52 Week High | $63.57 |
| 52 Week Low | $31.28 |
| Analyst Target Price | $54.83 |
| 50-Day Moving Average | $40.09 |
| 200-Day Moving Average | $49.52 |
| FINANCIAL DATA | |
| Revenue per Share | $5.08 |
| Revenue | $590,980,000 |
| Profit Margin | -37.8% |
| Return on Equity | -0.294% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TXG Compare Returns with S&P 500
TXG Trendline Chart